Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwenan M Knight

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
PLOS Global Public Health|October 16, 2025
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosisChaelin Kim, Sedona Sweeney, Hojoon Sohn, et al.
One Health (Amsterdam, Netherlands)|December 11, 2020
Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistanceNichola R Naylor, Jo Lines, Jeff Waage, et al.
Science Translational Medicine|October 8, 2020
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaRebecca C Harris, Tom Sumner, Gwenan M Knight, et al.
The Journal of Hospital Infection|May 10, 2026
Is Health Human Resource Strain Associated with the Prevalence of Healthcare-Associated Infections in England? Analysis of a national point prevalence surveyMatthew Driedger, Gwenan M Knight, Berit Muller-Pebody, et al.
Zoonoses and Public Health|February 4, 2021
The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: A systematic literature reviewDina Mohamed Youssef, Barbara Wieland, Gwenan M Knight, et al.
Msystems|March 21, 2022
Growth-Dependent Predation and Generalized Transduction of Antimicrobial Resistance by BacteriophageQuentin J Leclerc, Jacob Wildfire, Arya Gupta, et al.
The Lancet. Infectious Diseases|July 9, 2019
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modellingGwenan M Knight, C Finn McQuaid, Peter J Dodd, et al.
Wellcome Open Research|July 15, 2020
What settings have been linked to SARS-CoV-2 transmission clusters?Quentin J Leclerc, Naomi M Fuller, Lisa E Knight, et al.
Wellcome Open Research|July 15, 2020
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasetsQuentin J Leclerc, Nichola R Naylor, Alexander M Aiken, et al.
Plos One|May 13, 2014
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysisMariam O Fofana, Gwenan M Knight, Gabriela B Gomez, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
PLOS Global Public Health|October 16, 2025
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosisChaelin Kim, Sedona Sweeney, Hojoon Sohn, et al.
One Health (Amsterdam, Netherlands)|December 11, 2020
Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistanceNichola R Naylor, Jo Lines, Jeff Waage, et al.
Science Translational Medicine|October 8, 2020
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaRebecca C Harris, Tom Sumner, Gwenan M Knight, et al.
The Journal of Hospital Infection|May 10, 2026
Is Health Human Resource Strain Associated with the Prevalence of Healthcare-Associated Infections in England? Analysis of a national point prevalence surveyMatthew Driedger, Gwenan M Knight, Berit Muller-Pebody, et al.
Zoonoses and Public Health|February 4, 2021
The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: A systematic literature reviewDina Mohamed Youssef, Barbara Wieland, Gwenan M Knight, et al.
Msystems|March 21, 2022
Growth-Dependent Predation and Generalized Transduction of Antimicrobial Resistance by BacteriophageQuentin J Leclerc, Jacob Wildfire, Arya Gupta, et al.
The Lancet. Infectious Diseases|July 9, 2019
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modellingGwenan M Knight, C Finn McQuaid, Peter J Dodd, et al.
Wellcome Open Research|July 15, 2020
What settings have been linked to SARS-CoV-2 transmission clusters?Quentin J Leclerc, Naomi M Fuller, Lisa E Knight, et al.
Wellcome Open Research|July 15, 2020
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasetsQuentin J Leclerc, Nichola R Naylor, Alexander M Aiken, et al.
Plos One|May 13, 2014
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysisMariam O Fofana, Gwenan M Knight, Gabriela B Gomez, et al.
Pageof 8